Chinese defendants seek to regain initiative in US court fights with increased IPR filings
Beijing-based medical device manufacturer BMC Medical this week touted a recent inter partes review (IPR) decision knocking out a patent that competitor ResMed has used to sue the Chinese company in the US. The two companies make masks and…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe now